CytomX Therapeutics Inc (CTMX)
1.07
-0.02
(-1.83%)
USD |
NASDAQ |
Dec 24, 16:00
CytomX Therapeutics Cash from Investing (Quarterly): 18.17M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
Spero Therapeutics Inc | -- |
NovaBay Pharmaceuticals Inc | -0.002M |
Palatin Technologies Inc | 0.00 |
iBio Inc | 0.713M |
Theriva Biologics Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -20.73M |
Free Cash Flow | -88.78M |
Free Cash Flow Per Share (Quarterly) | -0.2435 |
Free Cash Flow to Equity (Quarterly) | -20.75M |
Free Cash Flow to Firm (Quarterly) | -20.75M |
Free Cash Flow Yield | -99.29% |